Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial.

MLA

Holland, Anne E., et al. “Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Controlled Trial.” BMJ Open, vol. 10, no. 12, Dec. 2020, p. e040798. EBSCOhost, https://doi.org/10.1136/bmjopen-2020-040798.

APA

Holland, A. E., Corte, T., Chambers, D. C., Palmer, A. J., Ekström, M. P., Glaspole, I., Goh, N. S. L., Hepworth, G., Khor, Y. H., Hoffman, M., Vlahos, R., Sköld, M., Dowman, L., Troy, L. K., Prasad, J. D., Walsh, J., & McDonald, C. F. (2020). Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial. BMJ Open, 10(12), e040798. https://doi.org/10.1136/bmjopen-2020-040798

Chicago

Holland, Anne E, Tamera Corte, Daniel C Chambers, Andrew J Palmer, Magnus Per Ekström, Ian Glaspole, Nicole S L Goh, et al. 2020. “Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Controlled Trial.” BMJ Open 10 (12): e040798. doi:10.1136/bmjopen-2020-040798.